He is also the bestselling author of Peptide Protocols (2020), The Redox Promise (2024), and The Quantum Power of GLP-1 Peptides (2025), and launched the popular podcast The Redox Promise in 2025
Free Radical Biol Med 30(11):11911212
Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor gene, the direct target of semaglutide), MC4R (a satiety-central melanocortin receptor), and TCF7L2 (linked to glucose homeostasis) map your baseline metabolic terrain
A placebo or one of the two treatments was administered to the participants for 8 weeks
The most common adverse events associated with GLP-1 receptor agonists are gastrointestinal symptoms, particularly nausea and vomiting, whereas pancreatitis represents a rare but clinically relevant concern